3sie
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | [[Image:3sie. | + | [[Image:3sie.png|left|200px]] |
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_3sie", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_3sie| PDB=3sie | SCENE= }} | {{STRUCTURE_3sie| PDB=3sie | SCENE= }} | ||
===Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors=== | ===Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors=== | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, {{ABSTRACT_PUBMED_21714539}}, adds the Publication Abstract to the page | ||
| - | (as it appears on PubMed at http://www.pubmed.gov), where 21714539 is the PubMed ID number. | ||
| - | --> | ||
{{ABSTRACT_PUBMED_21714539}} | {{ABSTRACT_PUBMED_21714539}} | ||
==About this Structure== | ==About this Structure== | ||
| - | [[3sie]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3SIE OCA]. | + | [[3sie]] is a 2 chain structure of [[Phosphodiesterase]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3SIE OCA]. |
| + | |||
| + | ==See Also== | ||
| + | *[[Phosphodiesterase|Phosphodiesterase]] | ||
==Reference== | ==Reference== | ||
Revision as of 04:27, 27 June 2012
Contents |
Crystal structure of the PDE5A1 catalytic domain in complex with novel inhibitors
Template:ABSTRACT PUBMED 21714539
About this Structure
3sie is a 2 chain structure of Phosphodiesterase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Xu Z, Liu Z, Chen T, Chen T, Wang Z, Tian G, Shi J, Wang X, Lu Y, Yan X, Wang G, Jiang H, Chen K, Wang S, Xu Y, Shen J, Zhu W. Utilization of Halogen Bond in Lead Optimization: A Case Study of Rational Design of Potent Phosphodiesterase Type 5 (PDE5) Inhibitors. J Med Chem. 2011 Aug 11;54(15):5607-11. Epub 2011 Jul 14. PMID:21714539 doi:10.1021/jm200644r
